Related Experiment Video
Updated: Jan 16, 2026
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
The intersection of ferroptosis and non-coding RNAs: a novel approach to lung cancer
Jian Ding1,2
1Department of Respiratory Medicine, The First Hospital of Qiqihar, Qiqihar, Heilongjiang Province, 161005, China. 252518789@qq.com.
Abstract:
Lung cancer remains a major global health challenge, with non-small cell lung cancer (NSCLC) accounting for nearly 85% of cases and deaths. Although advances in targeted therapy and immunotherapy have improved patient outcomes, drug resistance and limited long-term survival continue to pose serious obstacles. Ferroptosis, an iron-dependent and lipid peroxidation-driven form of regulated cell death, has attracted growing attention as a novel therapeutic approach to address these challenges. At the same time, non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs, and circular RNAs, are increasingly recognized as crucial regulators of cancer progression, therapy resistance, and cellular homeostasis. Recent studies reveal that ncRNAs and ferroptosis are closely interconnected in lung cancer, with ncRNAs influencing iron metabolism, antioxidant defense, and lipid peroxidation, thereby modulating sensitivity or resistance to ferroptotic death. Importantly, this crosstalk not only shapes tumor biology but also provides opportunities for clinical translation. Ferroptosis-related ncRNAs are emerging as potential biomarkers for prognosis, therapeutic response, and disease stratification. In addition, pharmacological induction of ferroptosis, combined with modulation of specific ncRNAs, offers a promising strategy to overcome resistance to chemotherapy, radiotherapy, and immunotherapy. This review highlights the latest advances in understanding the interplay between ncRNAs and ferroptosis in lung cancer and discusses their implications for precision medicine. By integrating ferroptosis induction with ncRNA-targeted strategies, new avenues may emerge for developing more effective and personalized therapies against NSCLC.
Insights
Non-coding RNAs (ncRNAs) and ferroptosis interact in lung cancer, influencing cell death and therapy resistance. Targeting this crosstalk offers new precision medicine strategies for non-small cell lung cancer (NSCLC).
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Non-small cell lung cancer (NSCLC) presents a significant global health burden, with drug resistance limiting current treatments.
- Ferroptosis, a regulated cell death pathway, and non-coding RNAs (ncRNAs) are emerging as key players in cancer biology and therapy.
- Understanding the interplay between ncRNAs and ferroptosis is crucial for developing novel therapeutic strategies against NSCLC.
Purpose of the Study:
- To review the latest research on the interaction between ncRNAs and ferroptosis in lung cancer.
- To discuss the implications of this crosstalk for precision medicine and therapeutic development.
- To highlight the potential of targeting ncRNAs and ferroptosis for overcoming treatment resistance in NSCLC.
Main Methods:
- Literature review of recent studies on ncRNAs, ferroptosis, and lung cancer.
- Analysis of the molecular mechanisms linking ncRNAs to ferroptosis regulation (iron metabolism, lipid peroxidation, antioxidant defense).
- Exploration of the clinical translational potential of ferroptosis-related ncRNAs as biomarkers and therapeutic targets.
Main Results:
- ncRNAs significantly modulate sensitivity to ferroptosis by regulating key pathways involved in iron metabolism, lipid peroxidation, and antioxidant defense in lung cancer cells.
- Ferroptosis-related ncRNAs show promise as biomarkers for prognosis, predicting therapeutic response, and stratifying NSCLC patients.
- The combination of ferroptosis induction and ncRNA modulation presents a viable strategy to overcome resistance to conventional therapies (chemotherapy, radiotherapy) and immunotherapy.
Conclusions:
- The intricate relationship between ncRNAs and ferroptosis offers novel therapeutic avenues for NSCLC.
- Targeting this crosstalk holds potential for developing more effective and personalized treatment strategies, improving long-term survival for lung cancer patients.
- Integrating ferroptosis induction with ncRNA-targeted approaches is a promising direction for future precision medicine in NSCLC.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
03:18Non-LTR Retrotransposons
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...